Agent Capital
Agent Capital is a healthcare venture capital firm focused on novel technologies and therapeutics that address unmet patient need.
Founded 2017 · Venture Capital
Waltham (
United States), Cambridge (United States)
United States), Cambridge (United States)Investment Stages
Seed
Series A
Series B
Series C
Markets
Rare Diseases
Oncology
Neurology
Immunology
Portfolio Companies
Affini-T, AshiBio, Carbon Biosciences, Carisma Therapeutics, Cerevance, Cyrus Biotechnology, Dice Therapeutics, Dragonfly Therapeutics, Entrada Therapeutics, Flare Therapeutics, Foresight Diagnostics, Freenome, Hinge Bio, ImCheck Therapeutics, Immunitas Therapeutics, Interius BioTherapeutics, Mediar Therapeutics, Metagenomi, Orbital Therapeutics, Orbus Therapeutics, Orchard Therapeutics, Palvella Therapeutics, Pliant Therapeutics, Precision Biosciences, Primrose Bio, Pyxis Oncology, Q32 Bio, Skyhawk Therapeutics, Star Therapeutics, TRex Bio, Verge Genomics, ViTToria Biotherapeutics, Zenas Biopharma
Links
Related VC firms in United States